Literature DB >> 17192313

Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.

Randall J Cohrs1, Donald H Gilden.   

Abstract

In human ganglia latently infected with varicella-zoster virus (VZV), sequence analysis has revealed that five viral genes (VZV genes 21, 29, 62, 63, and 66) are transcribed. However, their comparative prevalence and abundance are unknown. Here, using real-time PCR, we analyzed 28 trigeminal ganglia from 14 humans for RNA corresponding to the five virus genes known to be transcribed in latently infected human ganglia. The most prevalent transcript found was VZV gene 63 (78%), followed by gene 66 (43%), gene 62 (36%), and gene 29 (21%). No gene 21 transcripts were detected in any of the 28 ganglia. VZV gene 63 RNA was also the most abundant (3,710 +/- 6,895 copies per 1 microg of mRNA) transcript detected in latently infected human ganglia, followed by VZV gene 29 (491 +/- 594), VZV gene 66 (117 +/- 85), and VZV gene 62 (64 +/- 38). Thus, the repeated detection and high abundance of VZV gene 63 transcripts in latently infected ganglia suggests that VZV gene 63 may be more important for the maintenance of virus latency than the less abundantly transcribed and randomly detected VZV genes 21, 29, 62, and 66.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192313      PMCID: PMC1866015          DOI: 10.1128/JVI.02745-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures.

Authors:  R Tal-Singer; T M Lasner; W Podrzucki; A Skokotas; J J Leary; S L Berger; N W Fraser
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Transcriptomal analysis of varicella-zoster virus infection using long oligonucleotide-based microarrays.

Authors:  Peter G E Kennedy; Esther Grinfeld; Marie Craigon; Klemens Vierlinger; Douglas Roy; Thorsten Forster; Peter Ghazal
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

5.  Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA.

Authors:  R J Cohrs; M Barbour; D H Gilden
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Latent Varicella-zoster virus in human dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; J W Gow
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

7.  Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice.

Authors:  Lawrence T Feldman; Aaron R Ellison; Cynthia C Voytek; Li Yang; Philip Krause; Todd P Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

8.  Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons.

Authors:  M Kosz-Vnenchak; J Jacobson; D M Coen; D M Knipe
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia.

Authors:  R Cohrs; R Mahalingam; A N Dueland; W Wolf; M Wellish; D H Gilden
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

10.  Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.

Authors:  Randall J Cohrs; Donald H Gilden; Yasuyuki Gomi; Koichi Yamanishi; Jeffrey I Cohen
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more
  69 in total

1.  Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.

Authors:  Catia T Perciani; Bashir Farah; Rupert Kaul; Mario A Ostrowski; Salaheddin M Mahmud; Omu Anzala; Walter Jaoko; Kelly S MacDonald
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

2.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Varicella zoster virus in the temporal artery of a patient with giant cell arteritis.

Authors:  Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Robert Bert; Don Gilden
Journal:  J Neurol Sci       Date:  2013-10-02       Impact factor: 3.181

Review 4.  Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases.

Authors:  Angela Erazo; Paul R Kinchington
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Varicella-Zoster Virus (VZV) Small Noncoding RNAs Antisense to the VZV Latency-Encoded Transcript VLT Enhance Viral Replication.

Authors:  Punam Bisht; Biswajit Das; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

6.  Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries.

Authors:  Maria A Nagel; Alexander Choe; Nelly Khmeleva; Lindsey Overton; April Rempel; Ann Wyborny; Igor Traktinskiy; Don Gilden
Journal:  J Neurovirol       Date:  2013-03-01       Impact factor: 2.643

7.  Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner.

Authors:  Matthew S Walters; Christos A Kyratsous; Shilin Wan; Saul Silverstein
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.

Authors:  Niklaus H Mueller; Matthew S Walters; Roland A Marcus; Laurie L Graf; Jessica Prenni; Don Gilden; Saul J Silverstein; Randall J Cohrs
Journal:  J Gen Virol       Date:  2010-01-20       Impact factor: 3.891

9.  Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63.

Authors:  Niklaus H Mueller; Laurie L Graf; Andrew J Shearer; Gregory P Owens; Donald H Gilden; Randall J Cohrs
Journal:  Hybridoma (Larchmt)       Date:  2008-02

10.  Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.

Authors:  Ilhem Messaoudi; Alexander Barron; Mary Wellish; Flora Engelmann; Alfred Legasse; Shannon Planer; Don Gilden; Janko Nikolich-Zugich; Ravi Mahalingam
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.